Drug Trial Radar · NCT01801735
Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip
Last checked: Nov 19, 2026Latest source record: May 12, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Actual
Start
Mar 2013
Primary completion
Jun 2014
Study completion Aug 2014
Sponsor
- Lead sponsor
- Iroko Pharmaceuticals, LLCIndustry
- Sponsor type
- Industry
- First posted
- Mar 1, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip
Conditions
- Osteoarthritis
Interventions
Meloxicam Test CapsulesDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of Meloxicam 10 mg as Assessed by the Incidence of Adverse Events From Baseline to Week 52 or Early TerminationTime frame: Baseline to Week 52/Early Termination
Locations
40 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Phoenix, Arizona
Site not named
Carmichael, California
Site not named
Pismo Beach, California
Site not named
Milford, Connecticut
Site not named
DeLand, Florida
Site not named
Fleming Island, Florida
Site not named
Jacksonville, Florida
Site not named
Jacksonville, Florida
Site not named
Miami, Florida
Site not named
Ormond Beach, Florida
Site not named
Ponte Vedra, Florida
Site not named
Newton, Kansas
Site not named
Prairie Village, Kansas
Site not named
Wichita, Kansas
Site not named
Crestview Hills, Kentucky
Site not named
Brockton, Massachusetts
Site not named
Traverse City, Michigan
Site not named
Troy, Michigan
Site not named
Hazelwood, Missouri
Site not named
St Louis, Missouri
Site not named
Omaha, Nebraska
Site not named
Las Vegas, Nevada
Site not named
Hartsdale, New York
Site not named
Greensboro, North Carolina
Site not named
Cincinnati, Ohio
Site not named
Cincinnati, Ohio
Site not named
Cincinnati, Ohio
Site not named
Cincinnati, Ohio
Site not named
Columbus, Ohio
Site not named
Kettering, Ohio
Site not named
Duncansville, Pennsylvania
Site not named
Anderson, South Carolina
Site not named
Clinton, South Carolina
Site not named
Austin, Texas
Site not named
Plano, Texas
Site not named
San Antonio, Texas
Site not named
San Antonio, Texas
Site not named
Charlottesville, Virginia
Site not named
Roanoke, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.